See how a CRO’s experience and expertise in rare disease can be applied to multiple indications and showcase an organization’s capacity to make seminal contributions in design, methods of operations, and proposed analyses.
Authors:
Michael Murphy, MD, PhD
Chief Medical and Scientific Officer
